Overview


According to FutureWise analysis, the market for ablation devices is projected to expand at a CAGR of 12% from 2023-2031.

The ablation therapies are used for treating different diseases like cancer, gynaecological diseases, ophthalmic diseases and cardiovascular diseases. It is less painful than traditional surgeries as it a minimally invasive process resulting in the reduction of recovery times. Additionally, it causes less damage to the tissues surrounding the affected area. Although it lowers the side effects, it has certain disadvantages like ablation devices cannot treat bulky and large tissues like neck and bone nodules and these devices are not available in remote locations. Furthermore, the rising prevalence of patients with cardiovascular diseases in developed countries like the United States shall boost the ablation devices market growth. According to a data provided by St. Jude Medical Inc., over 240,000 catheter ablations were performed in the United States while over 980,000 patients were treated using ablation devices across the world. Moreover, the increased prevalence of cancer shall propel the market growth. As per the WHO, the number of newly registered cases are predicted to rise by over 65% in twenty years. Such an escalating prevalence of chronic diseases shall contribute to the proliferation of the market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Ablation Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Ablation Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  •  St. Jude Medical Inc.
  •  Medtronic plc
  •  Boston Scientific Corporation
  •  AngioDynamics, Inc.
  •  AtriCure, Inc.
  •  Conmed Corporation
  •  Olympus Corporation
  •  Smith and Nephew plc
  •  BTG plc
  •  Johnson and Johnson
  •  Accuray Incorporated
  •  C.R. Bard, Inc.
  •  Varian Medical Systems, Inc.
  •  Elekta AB
  •  Misonix, Inc.
  •  Hologic, Inc.
  •  Stryker Corporation
  •  EDAP TMS S.A.
  •  Japan Lifeline Co., Ltd.
  •  Halyard Health, Inc.
  •  Merit Medical Systems, Inc.
  •  Integra LifeSciences Holdings Corporation
  •  Abbott Laboratories
  •  Terumo Corporation.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Technology

  •  Thermal Ablation
    •  Electrical
      •  Electrical Ablators
        •  Argon Plasma/Beam Coagulator
        •  Irreversible Electroporation
      •  Electronic Brachytherapy
    •  Radiation
      •  Brachytherapy
        •  High-Dose-Rate Brachytherapy
        •  Pulsed-Dose-Rate Brachytherapy
        •  Permanent Seed Brachytherapy
      •  Stereotactic Radiotherapy and Radiosurgery
      •  Stereotactic Body Radiation
      •  Image Guided Radiation Therapy
      •  Intensity Modulated Radiation Therapy
      •  Proton Beam Therapy
    •  Radiofrequency
      •  Temperature Controlled
      •  Fluid Cooled
      •  Catheter Manipulation Systems
    •  Light
      •  Cold Lasers
      •  Excimer Lasers
    •  Ultrasound
      •  High Intensity Focused Ultrasound (HIFU)
      •  Magnetic Resonance Imaging-Guided Focused Ultrasound (MRI-FUS)
      •  Ultrasonic Surgical Systems
      •  Shock Wave Lithotripsy
    •  Microwave
    •  Hydrothermal
  •  Non-Thermal Ablation
    •  Cryoablation
      •  Tissue Contact Probe
      •  Cryogen Spray Probe
      •  Epidermal and Subcutaneous Cryoablation Devices
    •  Hydromechanical Ablation

By Application

  •  Cancer
  •  Cardiovascular
  •  Ophthalmology
  •  Gynecology
  •  Urology
  •  Orthopedics
  •  Others

By Procedure

  •  Aesthetics-Skin Rejuvenation and Tightening
  •  Aesthetics-Body Sculpting, Fat Reduction, And The Reduction in The Appearance of Cellulite
  •  Benign Prostatic Hyperplasia
  •  Transurethral Needle Ablation
  •  Laser and Other Energy-Based Therapies/Holmium Laser Ablation/Enucleation Of The Prostate
  •  Stress Urinary Incontinence
  •  Menorrhagia/Endometrial Ablation
  •  Uterine Fibroids
  •  Spinal Decompression and Denervation
  •  Varicose Veins
  •  Atrial Fibrillation
  •  Tumor Ablation
  •  Others

By Function

  •  Automated/Robotic
  •  Conventional

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

The North America region is expected to lead the market during the forecasted timeframe owing to a strong presence of major market players in the region. Furthermore, unhealthy dietary habits, lack of exercise and rising geriatric population has increased the number of patients diagnosed with cardiovascular diseases in the region. Many key players and even emerging companies have focussed on increasing their research and development activities in the region.

  •  Tier 1 players- established companies in the market with a major market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrant
  •  Growth prospects
  •  SWOT analysis
  •  Key market trends
  •  Key data-points affecting market growth
  •  To provide with an exhaustive analysis on the global ablation devices market By Technology, By Application, By Procedure, By Function and By Region
  •  To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  •  To evaluate and forecast micro-markets and the overall market
  •  To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  •  To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •  The customization Mobility Care offered are free of charge with purchase of any license of the report
  •  You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Ablation Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Ablation Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Ablation Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Ablation Devices Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Thermal Ablation
         1.1. Electrical
          1.1.1. Electrical Ablators
           1.1.1.1. Argon Plasma/Beam Coagulator
           1.1.1.2. Irreversible Electroporation
          1.1.2. Electronic Brachytherapy
         1.2. Radiation
          1.2.1. Brachytherapy
           1.2.1.1. High-Dose-Rate Brachytherapy
           1.2.1.2. Pulsed-Dose-Rate Brachytherapy
           1.2.1.3. Permanent Seed Brachytherapy
          1.2.2. Stereotactic Radiotherapy and Radiosurgery
          1.2.3. Stereotactic Body Radiation
          1.2.4. Image Guided Radiation Therapy
          1.2.5. Intensity Modulated Radiation Therapy
          1.2.6. Proton Beam Therapy
         1.3. Radiofrequency
          1.3.1. Temperature Controlled
          1.3.2. Fluid Cooled
          1.3.3. Catheter Manipulation Systems
         1.4. Light
          1.4.1. Cold Lasers
          1.4.2. Excimer Lasers
         1.5. Ultrasound
          1.5.1. High Intensity Focused Ultrasound (HIFU)
          1.5.2. Magnetic Resonance Imaging-Guided Focused Ultrasound (MRI-FUS)
          1.5.3. Ultrasonic Surgical Systems
          1.5.4. Shock Wave Lithotripsy
         1.6. Microwave
         1.7. Hydrothermal
        2. Non-Thermal Ablation
         2.1. Cryoablation
          2.1.1. Tissue Contact Probe
          2.1.2. Cryogen Spray Probe
          2.1.3. Epidermal and Subcutaneous Cryoablation Devices
         2.2. Hydromechanical Ablation

  • 8.   Ablation Devices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cancer
        2. Cardiovascular
        3. Ophthalmology
        4. Gynecology
        5. Urology
        6. Orthopedics
        7. Others

  • 9.   Ablation Devices Market, By Procedure Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Aesthetics-Skin Rejuvenation and Tightening
        2. Aesthetics-Body Sculpting, Fat Reduction, And The Reduction in The Appearance of Cellulite
        3. Benign Prostatic Hyperplasia
        4. Transurethral Needle Ablation
        5. Laser and Other Energy-Based Therapies/Holmium Laser Ablation/Enucleation Of The Prostate
        6. Stress Urinary Incontinence
        7. Menorrhagia/Endometrial Ablation
        8. Uterine Fibroids
        9. Spinal Decompression and Denervation
        10. Varicose Veins
        11. Atrial Fibrillation
        12. Tumor Ablation
        13. Others

  • 10.   Ablation Devices Market, By Function Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Automated/Robotic
        2. Conventional

  • 11.   North America Ablation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Ablation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Ablation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Ablation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. St. Jude Medical Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Medtronic plc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Boston Scientific Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. AngioDynamics, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. AtriCure, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Conmed Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Olympus Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Smith and Nephew plc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. BTG plc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
         10. Johnson and Johnson
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
          11. Accuray Incorporated
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
          12. C.R. Bard, Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
          13. Varian Medical Systems, Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Elekta AB
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
          15. Misonix, Inc.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
          16. Hologic, Inc.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
          17. Stryker Corporation
         1. Company Overview
         2. Product Portfolio
         3. SWOT Analysis
         4. Financial Overview
         5. Strategic Overview
          18. EDAP TMS S.A.
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
         19. Japan Lifeline Co.ltd.
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
         20. Halyard Health, Inc.
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
         21. Merit Medical Systems, Inc.
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
         22. Integra LifeSciences Holdings Corporation
         22.1. Company Overview
         22.2. Product Portfolio
         22.3. SWOT Analysis
         22.4. Financial Overview
         22.5. Strategic Overview
         23. Abbott Laboratories
         23.1. Company Overview
         23.2. Product Portfolio
         23.3. SWOT Analysis
         23.4. Financial Overview
         23.5. Strategic Overview
         24. Terumo Corporation
         24.1. Company Overview
         24.2. Product Portfolio
         24.3. SWOT Analysis
         24.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients